197 related articles for article (PubMed ID: 20434891)
1. Effect of formulations variables on the in vitro percutaneous permeation of Sodium Diclofenac from new vesicular systems obtained from Pluronic triblock copolymers.
Tavano L; Muzzalupo R; Trombino S; Cassano R; Pingitore A; Picci N
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):227-34. PubMed ID: 20434891
[TBL] [Abstract][Full Text] [Related]
2. Drug compartmentalization as strategy to improve the physico-chemical properties of diclofenac sodium loaded niosomes for topical applications.
Tavano L; de Cindio B; Picci N; Ioele G; Muzzalupo R
Biomed Microdevices; 2014 Dec; 16(6):851-8. PubMed ID: 25129111
[TBL] [Abstract][Full Text] [Related]
3. A new approach for the evaluation of niosomes as effective transdermal drug delivery systems.
Muzzalupo R; Tavano L; Cassano R; Trombino S; Ferrarelli T; Picci N
Eur J Pharm Biopharm; 2011 Sep; 79(1):28-35. PubMed ID: 21303691
[TBL] [Abstract][Full Text] [Related]
4. Photostability and ex-vivo permeation studies on diclofenac in topical niosomal formulations.
Ioele G; Tavano L; De Luca M; Ragno G; Picci N; Muzzalupo R
Int J Pharm; 2015 Oct; 494(1):490-7. PubMed ID: 26307262
[TBL] [Abstract][Full Text] [Related]
5. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
Carmona-Moran CA; Zavgorodnya O; Penman AD; Kharlampieva E; Bridges SL; Hergenrother RW; Singh JA; Wick TM
Int J Pharm; 2016 Jul; 509(1-2):465-476. PubMed ID: 27260133
[TBL] [Abstract][Full Text] [Related]
6. Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications.
Bachhav YG; Heinrich A; Kalia YN
Eur J Pharm Biopharm; 2011 Aug; 78(3):408-14. PubMed ID: 21397689
[TBL] [Abstract][Full Text] [Related]
7. Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula.
Escribano E; Calpena AC; Queralt J; Obach R; Doménech J
Eur J Pharm Sci; 2003 Jul; 19(4):203-10. PubMed ID: 12885384
[TBL] [Abstract][Full Text] [Related]
8. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route.
Jain S; Patel N; Madan P; Lin S
Pharm Dev Technol; 2015 Jun; 20(4):473-89. PubMed ID: 24490793
[TBL] [Abstract][Full Text] [Related]
9. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin.
Tavano L; Alfano P; Muzzalupo R; de Cindio B
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):333-9. PubMed ID: 21684725
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs.
Caddeo C; Sales OD; Valenti D; Saurí AR; Fadda AM; Manconi M
Int J Pharm; 2013 Feb; 443(1-2):128-36. PubMed ID: 23299087
[TBL] [Abstract][Full Text] [Related]
11. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.
Arora P; Mukherjee B
J Pharm Sci; 2002 Sep; 91(9):2076-89. PubMed ID: 12210054
[TBL] [Abstract][Full Text] [Related]
12. Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies.
Liu D; Ge Y; Tang Y; Yuan Y; Zhang Q; Li R; Xu Q
J Microencapsul; 2010; 27(8):726-34. PubMed ID: 21034365
[TBL] [Abstract][Full Text] [Related]
13. Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery.
Malinovskaja-Gomez K; Espuelas S; Garrido MJ; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2017 Aug; 106():294-301. PubMed ID: 28625748
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation.
Dasgupta S; Ghosh SK; Ray S; Mazumder B
Curr Drug Deliv; 2013 Dec; 10(6):656-66. PubMed ID: 24274634
[TBL] [Abstract][Full Text] [Related]
15. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
Sharma G; Goyal H; Thakur K; Raza K; Katare OP
Drug Deliv; 2016 Oct; 23(8):3135-3145. PubMed ID: 26960815
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of xanthan gum-facilitated ethyl cellulose microsponges for controlled percutaneous delivery of diclofenac sodium.
Maiti S; Kaity S; Ray S; Sa B
Acta Pharm; 2011 Sep; 61(3):257-70. PubMed ID: 21945905
[TBL] [Abstract][Full Text] [Related]
17. Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment.
Abidin L; Mujeeb M; Imam SS; Aqil M; Khurana D
Drug Deliv; 2016; 23(3):1079-84. PubMed ID: 25116512
[TBL] [Abstract][Full Text] [Related]
18. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery.
El Zaafarany GM; Awad GA; Holayel SM; Mortada ND
Int J Pharm; 2010 Sep; 397(1-2):164-72. PubMed ID: 20599487
[TBL] [Abstract][Full Text] [Related]
19. A novel solid-in-oil nanosuspension for transdermal delivery of diclofenac sodium.
Piao H; Kamiya N; Hirata A; Fujii T; Goto M
Pharm Res; 2008 Apr; 25(4):896-901. PubMed ID: 17896098
[TBL] [Abstract][Full Text] [Related]
20. Cationic polymer-based micro-emulgel with self-preserving ability for transdermal delivery of diclofenac sodium.
Yang C; Shen Y; Wang J; Ouahab A; Zhang T; Tu J
Drug Deliv; 2015; 22(6):814-22. PubMed ID: 24724988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
